Julien's Primer of Drug Action

Julien’s Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations.  

The thoroughly updated 14th edition features:

New coverage of opioids of abuse, and  drugs used to treat of opioid dependence and opioid overdose

New research on the use of marijuana to treat Alzheimers, PTSD,  and Epilepsy

New coverage of pharmacological, physiological, and psychoactive effects  of synthetic marijuana including its toxicity

New research on Cannabidiol (CBD) and its therapeutic uses

New research of the efficacy of  antipsychotics to treat  dementia, Parkinson’s, bipolar, OCD, and PTSD

The use of genetic testing to predict effectiveness of antidepressant treatment

New research on the use of ketamine for the treatment of depression